Analysis of plasma from prostate cancer patients links decreased carnosine dipeptidase 1 levels to lymph node metastasis

Translational Proteomics

Volumn 2, Issue 1, 2014, Pages 14-24

  Qundos, Ulrika ^a   Johannesson, Henrik ^b   Fredolini, Claudia ^a   O'Hurley, Gillian ^c   Branca, Rui ^d   Uhlén, Mathias ^a   Wiklund, Fredrik ^d   Bjartell, Anders ^e   Nilsson, Peter ^a   Schwenk, Jochen M ^a  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^b ALBANOVA UNIVERSITY CENTER   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Carnosine dipeptidase 1; Plasma biomarker; Prostate cancer; Sandwich immunoassay; Suspension bead array

Indexed keywords

CARNOSINE DIPEPTIDASE 1; ENZYME ANTIBODY; ONCOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME GLYCOSYLATION; ENZYME IMMUNOASSAY; EPITOPE MAPPING; HUMAN; LYMPH NODE METASTASIS; MALE; PREDICTION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROSTATE CANCER; WESTERN BLOTTING;

EID: 84959320875     PISSN: 22129626     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trprot.2013.12.001     Document Type: Article

References (20)

1. Pin E., Fredolini C., Petricoin E.F. The role of proteomics in prostate cancer research: biomarker discovery and validation. Clin Biochem 2013, 46:524-538.
2. Stoevesandt O., Taussig M.J. Affinity proteomics: the role of specific binding reagents in human proteome analysis. Expert Rev Proteomics 2012, 9:401-414.
3. Ayoglu B., Haggmark A., Neiman M., Igel U., Uhlen M., Schwenk J.M., et al. Systematic antibody and antigen-based proteomic profiling with microarrays. Expert Rev Mol Diagn 2011, 11:219-234.
4. Fagerberg L., Oksvold P., Skogs M., Algenas C., Lundberg E., Ponten F., et al. Contribution of antibody-based protein profiling to the human chromosome-centric proteome project (C-HPP). J Proteome Res 2013, 12(6):2439-2448.
5. Schwenk J.M., Igel U., Neiman M., Langen H., Becker C., Bjartell A., et al. Toward next generation plasma profiling via heat-induced epitope retrieval and array-based assays. Mol Cell Proteomics 2010, 9:2497-2507.
6. Peters V., Jansen E.E., Jakobs C., Riedl E., Janssen B., Yard B.A., et al. Anserine inhibits carnosine degradation but in human serum carnosinase (CN1) is not correlated with histidine dipeptide concentration. Clin Chim Acta 2011, 412:263-267.
7. Adelmann K., Frey D., Riedl E., Koeppel H., Pfister F., Peters V., et al. Different conformational forms of serum carnosinase detected by a newly developed sandwich ELISA for the measurements of carnosinase concentrations. Amino Acids 2012, 43:143-151.
8. Lenney J.F., George R.P., Weiss A.M., Kucera C.M., Chan P.W., Rinzler G.S. Human serum carnosinase: characterization, distinction from cellular carnosinase, and activation by cadmium. Clin Chim Acta/Int J Clin Chem 1982, 123:221-231.
9. Teufel M., Saudek V., Ledig J.P., Bernhardt A., Boularand S., Carreau A., et al. Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase. J Biol Chem 2003, 278:6521-6531.
10. Liu T., Qian W.J., Gritsenko M.A., Camp D.G., Monroe M.E., Moore R.J., et al. Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. J Proteome Res 2005, 4:2070-2080.
11. Burgess E.F., Ham A.J., Tabb D.L., Billheimer D., Roth B.J., Chang S.S., et al. Prostate cancer serum biomarker discovery through proteomic analysis of alpha-2 macroglobulin protein complexes. Proteomics Clin Appl 2008, 2:1223.
12. Ahluwalia T.S., Lindholm E., Groop L.C. Common variants in CNDP1 and CNDP2, and risk of nephropathy in type 2 diabetes. Diabetologia 2011, 54:2295-2302.
13. Janssen B., Hohenadel D., Brinkkoetter P., Peters V., Rind N., Fischer C., et al. Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Diabetes 2005, 54:2320-2327.
14. Hjelm B., Forsstrom B., Igel U., Johannesson H., Stadler C., Lundberg E., et al. Generation of monospecific antibodies based on affinity capture of polyclonal antibodies. Protein Sci 2011, 20:1824-1835.
15. R Development Core Team R: a language and environment for statistical computing 2011, R Foundation for Statistical Computing, Vienna, Austria.
16. Magnelli P., Bielik A., Guthrie E. Identification and characterization of protein glycosylation using specific endo- and exoglycosidases. Methods Mol Biol 2012, 801:189-211.
17. Buck C.A., Glick M.C., Warren L. Glycopeptides from the surface of control and virus-transformed cells. Science 1971, 172:169-171.
18. Kyselova Z., Mechref Y., Al Bataineh M.M., Dobrolecki L.E., Hickey R.J., Vinson J., et al. Alterations in the serum glycome due to metastatic prostate cancer. J Proteome Res 2007, 6:1822-1832.
19. Lau K.S., Dennis J.W. N-glycans in cancer progression. Glycobiology 2008, 18:750-760.
20. Licker V., Cote M., Lobrinus J.A., Rodrigo N., Kovari E., Hochstrasser D.F., et al. Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson's disease. J Proteomics 2012, 75:4656-4667.